Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicentre, Interventional, Randomised, Assessor-blinded Trial to MAXimise the METHotrexate Therapy Potential in Patients With Active Rheumatoid Arthritis

NCT06649136 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06649136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicentre, Interventional, Randomised, Assessor-blinded Trial to MAXimise the METHotrexate Therapy Potential in Patients With Active Rheumatoid Arthritis
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Recruiting
Start date
August 12, 2024
Completion date
June 7, 2027
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis